Health
2.3m Register for COVID-19 Vaccination in 24 Hours—NPHCDA
By Ahmed Rahma
No fewer than 2.3 million persons living in Nigeria have registered for COVID-19 vaccination in less than 24 hours, the National Primary Health Care Development Agency (NPHCDA) has disclosed.
On Tuesday, Nigeria received nearly 4 million doses of the Oxford/AstraZeneca COVID-19 jabs to be given to less than 2 million people in two doses each.
Before the arrival of the vaccines, there were insinuations in some quarters that the jabs were meant to achieve other ulterior motives, with people discouraged from being vaccinated.
But on Wednesday, NPHCDA dispelled fears that people may not want to be vaccinated against COVID-19, disclosed that up to 2.3 million persons have already registered for vaccination.
The agency, through its Executive Director, Mr Faisal Shuaib, said the jabs were safe, noting that there was enthusiasm in Nigeria over the arrival of the doses.
“I can tell you that there is a lot of excitement [about the vaccine arrival]. I know some people have their concerns and we are trying but I want to give you an example of the enthusiasm that Nigerians are showing around wanting to take these vaccines,” the medical practitioner said during an interview on Channels Television’s Sunrise Daily.
“Around midday on Monday when we launched the e-registration platform, in less than 24 hours, we already had up to 2.3m Nigerians who had registered. And that number continues to increase.”
While the arrival of the first batch of vaccines is a major boost in Nigeria’s fight against the disease which has been contracted by over 150,000 people in the nation, Dr Faisal said there is still much work to be done.
“So, we take that very seriously and this is why we are going to be working very hard,” he added. “Yes, the vaccines are here, but there is even harder work that needs to go on to make sure that we deliver the vaccines into the arms of Nigerians in a way that is respectful, in a way that is stress-free.”
He explained that the agency has put plans in place for the rollout of the vaccine and that it is only waiting for the approval of the National Agency for Food and Drug Administration and Control (NAFDAC).
“So, we are waiting on NAFDAC,” he noted. “We feel that they are going to do all of the checks that are necessary and once they give us the green light, we will be ready to roll out the vaccines.”
The NPHCDA boss also dismissed rumours that the vaccines have been allotted to the high and mighty in the society, maintaining that frontline health workers and those exposed to the virus will be given priority in the administration of the jabs.
“I will tell you categorically that we have not allotted these vaccines to the rich people or to the people in the urban areas, absolutely not. Mr President has been very clear,” Dr Faisal maintained.
“Mr Vice President has also added his voice and the Chairman of the Presidential Task Force has communicated this in the Presidential Task Force media briefings.
“He has made it very clear in terms of who we are going to prioritise and I will repeat it here again that the first group of people who are going to be taking these vaccines are those people who have sacrificed in the last one year taking care of all Nigerians that have come down with COVID-19. So, frontline health workers first.
“On Friday, we are going to be launching the vaccines, we are going to be rolling them out at the treatment centres at the national hospital. Our priority will be the health workers that are frontline. We are going to be giving these vaccines to first responders.”
Aside from health workers, he noted that some leaders will be vaccinated. This, he said, will convince more Nigerians to take the shots.
“We are going to be looking at those strategic leaders like Mr President and the Vice-President, those people who will also want to take the vaccines publicly so that they can motivate the followers to take the vaccines, to convince them that the vaccines are very safe,” the NPHCDA leader noted.
By Adedapo Adesanya
The National Health Insurance Authority (NHIA) says the number of Nigerians enrolled in health insurance has risen to more than 22 million.
The Director-General of NHIA, Mr Kelechi Ohiri, said this resulted from the implementation of the mandatory health insurance, which has gained momentum nationwide.
He said this on Wednesday at the Annual General Meeting of the Nigerian Association of Insurance and Pension Editors (NAIPE) in Lagos.
Mr Ohiri said enrolment had increased to 22.03 million, representing a 35 per cent year-on-year growth, attributing this to stronger collaboration with state social health insurance agencies, ministries, departments and agencies, organised labour, employers, the private sector, and the gradual implementation of the mandatory health insurance provisions of the NHIA Act.
He said that the country had moved beyond policy formulation to delivering measurable improvements in healthcare access, service quality and consumer protection in line with the federal government’s health sector reform agenda.
According to him, Nigeria already has the necessary policies and legislation to achieve Universal Health Coverage, positing that the key challenge was effective implementation.
“The decisive variable is now implementation- consistent, rigorous and accountable execution that converts political commitment into healthcare access for real Nigerians,” he said.
Mr Ohiri said that the transition from the former National Health Insurance Scheme to the NHIA had strengthened regulation, consumer protection, accountability and strategic purchasing, while providing the legal and operational framework for achieving Universal Health Coverage.
He added that improving the experience of enrollees remained central to the Authority’s reform agenda.
According to him, NHIA has strengthened its complaints management system, introduced faster resolution timelines, and intensified compliance monitoring of Health Maintenance Organisations (HMOs) and healthcare providers.
He further added that NHIA had sanctioned facilities that failed to meet the required standards, adding that his organisation had resolved 3,878 complaints, representing an 87 per cent resolution rate, while 95 per cent of the cases were concluded within prescribed timelines.
Mr Ohiri noted that more than N14.2 million had been refunded to enrollees, while non-compliant healthcare facilities had been sanctioned.
He said NHIA had also introduced service standards, including a one-hour treatment commencement target for enrollees requiring urgent care, to improve access to timely and quality healthcare services.
The NHIA boss further disclosed that capitation payments to healthcare providers had been increased by 93 per cent.
He said fee-for-service reimbursements rose by 378 per cent to enable providers to invest more in personnel, equipment and infrastructure.
According to him, 7,592 healthcare facilities have been assessed under the SafeCare quality framework as part of efforts to institutionalise continuous quality improvement across the country.
Mr Ohiri also highlighted interventions targeted at vulnerable groups, including support for more than 48,500 pregnant women, expanded maternal and newborn healthcare services, the Vulnerable Group Fund, and improved access to healthcare for pensioners and retirees.
He said Universal Health Coverage could only be achieved if every Nigerian, regardless of income or location, had access to quality healthcare services.
By Modupe Gbadeyanka
The new one-hour authorisation response time ultimatum policy introduced by the National Health Insurance Authority (NHIA) has received the full backing of SUNU Health Nigeria Limited.
This policy was introduced by the agency to ensure enrollees get prompt approval codes to access care.
Healthcare service providers have been urged to report any Health Maintenance Organisation (HMO) that violates this initiative through an email, with the HMO in copy and a timestamp attached as evidence of the request. They may proceed to offer services to enrollees thereafter.
Speaking at the company’s second-quarter Providers’ Forum for the Lagos-Ogun region in Lagos recently, the chief executive of SUNU Health, Dr Moyosore Olomola, expressed optimism that this policy would improve healthcare delivery in the country, especially for enrollees, who crave quality service.
At the event themed Improving Quality and Access to Care Through Stronger Provider Network, and held at the Nigerian Institute of Medical Research (NIMR) in Yaba, Lagos, Mr Olomola reaffirmed the HMO’s commitment to operating within legal and operational frameworks to guarantee adequate care for enrollees.
“Access to care and quality of care remain key priorities in our healthcare systems. We know quite well that deliberate collaboration, strategic partnerships, and a shared commitment to excellence are required to achieve these priorities.
“A strong provider network is doubtless the backbone of any effective healthcare system. It ensures that our mutual enrollees receive the right care, at the right time, in the right place, and at the right price,” Mr Olomola, represented at the programme by the organisation’s Chief Operating Officer (COO), Dr Faith Nwachi, stated.
He further assured that SUNU Health would strictly adhere to the one-hour authorisation limit, stressing that this aligns seamlessly with one of the organisation’s core values—promptness and its corporate slogan, Humanity is the centre of our initiatives.
In a bid to further improve access and quality of care, SUNU Health also demonstrated its new operational software and Mobile app, aptly named SUNU Legacy.
Also speaking at the event, the NHIA Lagos State Coordinator (Ikeja), Dr Bethuel-Kasimu Abraham, noted that the forum’s expected outcome is to significantly reduce delays in accessing medical care.
Other key expectations include ensuring continuity of care, improving patient outcomes, and strengthening accountability among HMOs.
Addressing specific pain points faced by enrollees, the NHIA Ogun State Coordinator, Mr Dare Adefeso, acknowledged that the agency had received complaints regarding out-of-stock drugs and the discrimination of enrollees by certain providers.
He affirmed that the NHIA is actively addressing these issues, stressing that moving forward, every facility must ensure enrollees are properly catered to regardless of their status, provided they have an active health insurance plan.
Corroborating the long-standing legacy of SUNU Health, the Ogun State Director of the National Orientation Agency (NOA), Mrs Aishat Tiamiyu, shared that her agency is responsible for public information dissemination and has been enrolled with SUNU Health for over 25 years.
Commending the HMO’s stellar service over two decades, she called for the immediate enrollment of new NOA staff into the scheme.
The Providers’ Forum remains one of the strategic channels employed by SUNU Health to consistently engage healthcare providers, understand their operational challenges, introduce new software updates, and solidify partnerships aimed at fostering premium healthcare delivery across Nigeria.
By Aduragbemi Omiyale
The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the recall of a sexual enhancement product known as WAP Sensual Enhancement Capsules.
In a statement on Monday, the Nigerian agency disclosed that the recall is due to “undeclared pharmaceutical ingredients” in the product, whose country of origin is unknown, but is marketed and distributed online in the US through eBay.
It was emphasised that the recall is being “voluntarily” made by the manufacturer, Best Supplements Best Prices Company.
The detection of the undeclared pharmaceutical ingredients was made by the US Food and Drug Administration (FDA).
Laboratory analysis by the US FDA revealed that the product contained undeclared sildenafil, tadalafil, and flibanserin, which were not mentioned on the product label. Such substances may include phosphodiesterase type-5 (PDE-5) inhibitors or related compounds commonly used for the treatment of erectile dysfunction, the statement by NAFDAC stated.
Sildenafil and tadalafil are ingredients in FDA-approved prescription drugs used to treat erectile dysfunction.
It was noted that these undeclared ingredients may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.
Flibanserin is the active ingredient in an FDA-approved prescription drug used to treat low sexual desire in women. Flibanserin can cause drowsiness, sedation, dangerously low blood pressure, and fainting, especially when combined with alcohol.
Consumers have been encouraged to report compromised products (medicines or medical devices) to the nearest NAFDAC office, call 0800-162-3322, or send an email to sf******@********ov.ng.
